Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Vertex Pharmaceuticals (NQ: VRTX ) 473.82 -1.13 (-0.24%) Streaming Delayed Price Updated: 4:00 PM EDT, Jun 25, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about Vertex Pharmaceuticals < Previous 1 2 3 4 5 6 7 8 9 ... 43 44 Next > Biotech Stocks Heat As Arvinas Scores Novartis Licensing Pact, Janux Reportedly Explores Options April 11, 2024 Novartis snagged a licensing deal with Arvinas worth up to $1.16 billion, while Janux is said to be exploring its options. Via Investor's Business Daily Vertex Pharmaceuticals: Buy, Sell, or Hold? April 11, 2024 The stock hasn't made for a great buy this year, but is Vertex worth investing in for the long run? Via The Motley Fool Vertex Pharmaceuticals Moves Beyond $10B Cystic Fibrosis Franchise, Pays Around $5B For Kidney Disease Player Alpine Immune April 11, 2024 Vertex Pharmaceuticals to acquire Alpine Immune Sciences for $4.9 billion in cash. Povetacicept, a potent dual antagonist of BAFF and APRIL, shows promise in IgA nephropathy. Transaction expected to... Via Benzinga Wall Street Braces For Another Red Day Ahead Of More Inflation Data While Bitcoin Holds Above $70K: Analyst Sees Any Pullback As 'Phenomenal Buying Opportunity' April 11, 2024 The negative mood on Wall Street may persist as investors await the release of another inflation report, which will have significant implications for the near-term trend in cons Via Benzinga Topics Economy Exposures Interest Rates 1 Top Growth Stock to Buy and Hold Forever March 31, 2024 This drugmaker looks unstoppable. Via The Motley Fool If You Invested $100 In This Stock 20 Years Ago, You Would Have $4,400 Today March 25, 2024 Via Benzinga Vertex Pharmaceuticals Nabs Alpine Immune Sciences In $4.9 Billion Deal April 10, 2024 The companies expect the deal to close later this quarter. Via Investor's Business Daily This Growth Stock Is One Step Closer to Launching a New Blockbuster: Time to Buy? April 09, 2024 This innovative machine rolls on. Via The Motley Fool Jim Cramer Was Upset At This Hostile Takeover, But 'They Fixed The Situation. Stock's Been A Horse' April 09, 2024 On CNBC’s "Mad Money Lightning Round," Jim Cramer said he prefers Abbott Laboratories (NYSE: ABT) over Via Benzinga 3 High-Growth Biotech Stocks Investors Shouldn’t Sleep On in April April 09, 2024 These high-growth biotech stocks are certainly worth considering for investors looking for market-beating returns in the long-term. Via InvestorPlace Missed Out on Eli Lilly? 2 Healthcare Stocks With Big Catalysts on the Horizon. April 09, 2024 These companies are close to launching new products that could supercharge revenue. Via The Motley Fool Got $1,000? 2 Bulletproof Stocks to Buy in 2024 and Hold for the Long Haul April 05, 2024 These businesses are booming. Via The Motley Fool Missed the "Magnificent Seven"? Try Buying These 3 Forever Stocks Instead April 01, 2024 All three companies have very long runways for growth ahead. Via The Motley Fool Meet The "Magnificent Seven" of Healthcare Stocks April 01, 2024 The tech sector doesn't have a monopoly on magnificent corporations. Via The Motley Fool 2 Rock-Solid Growth Stocks to Buy Right Now and Hold for at Least 5 Years March 31, 2024 Great businesses are here to stay. These are two excellent examples. Via The Motley Fool 3 Unstoppable Stocks to Buy Hand Over Fist in April March 30, 2024 These stocks have exceptionally bright prospects. Via The Motley Fool 10 Health Care Stocks With Whale Alerts In Today's Session March 28, 2024 Via Benzinga Crispr Stock, A Cathie Wood Holding, Dives For The Fifth Straight Week — Here's Why March 28, 2024 The company is working to launch its Vertex-partnered gene-editing drug for sickle cell disease and beta thalassemia. Via Investor's Business Daily 3 Biotech Stocks to Buy for the Next Bull Run: March 2024 March 26, 2024 These biotech stocks to buy are well positioned for growth, and will generate solid returns for investors in the next bull run. Via InvestorPlace Wall Street’s Favorite Biotech Stocks? 3 Names That Could Make You Filthy Rich March 25, 2024 Some of the market’s favorite biotech stocks have created immense wealth, as evidenced with the recent weight-loss drug stock boom. Via InvestorPlace 3 Biopharma Stocks Predicted to Soar in Q2 2024 March 20, 2024 These biopharma stocks can produce massive returns for Q2 based on new product releases and international treatment approvals. Via InvestorPlace From Six Figures to Seven: 3 Biotech Stocks Set to Make Millionaires March 19, 2024 These biotech stocks to buy offer a gateway to long-term gains, on the back of groundbreaking healthcare innovations. Via InvestorPlace 2 No-Brainer Healthcare Stocks to Buy With $1,000 Right Now March 17, 2024 It's always a good time to buy great stocks with excellent prospects. Via The Motley Fool 3 Unstoppable Stocks You Can Buy Now Without Any Hesitation March 17, 2024 There's no need for delays in buying these great stocks. Via The Motley Fool Forget Tesla, Buy This Magnificent Healthcare Stock Instead March 17, 2024 Vertex Pharmaceuticals already has a fantastic business, and it could get much bigger in the future. Via The Motley Fool Missed Out on Eli Lilly? 3 Healthcare Stocks With Big Catalysts on the Horizon. March 09, 2024 Good news could be in store for all three of these drugmakers. Via The Motley Fool Here's How Much You Would Have Made Owning Vertex Pharmaceuticals Stock In The Last 15 Years March 08, 2024 Via Benzinga The Top 3 Biotech Stocks to Buy in March 2024 March 06, 2024 Although the biotech sector puts the benefits and risks in plain sight, three top biotech stocks to buy shine for investors. Via InvestorPlace 3 Biopharma Stocks You Don't Want to Miss in the New Bull Market March 05, 2024 All three have exciting programs on the way. Via The Motley Fool Game Changers: 3 Biotech Stocks That Could Be Multibaggers in the Making March 05, 2024 These three companies represent the world of biotech stocks and offer a unique blend of high risk and potentially high reward. Via InvestorPlace < Previous 1 2 3 4 5 6 7 8 9 ... 43 44 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.